Navigation Links
Inverness Medical Innovations Announces Fourth Quarter 2007 Results
Date:2/20/2008

GAAP Adjustments Basis(a)

Net revenue $157,008 $- $157,008

Cost of sales 89,680 (3,906)(b)(c)(d) 85,774

Gross profit 67,328 3,906 71,234

Gross margin 43% 45%

Operating expenses:

Research and

development 13,917 (1,460)(c)(d) 12,457

Purchase of in-process

research and

development - - -

Selling, general and

administrative 44,584 (2,493)(c)(d) 42,091

Loss on dispositions,

net 307 (307)(e) -

Operating income 8,520 8,166 16,686

Interest and other income

(expense), net (650) 177(c) (473)

Income tax (benefit)

provision 1,843 552(i) 2,395

Net (loss) income $6,027 $7,791 $13,818

Net (loss) income per

common share:

Basic $0.15 $0.36

Diluted $0.15(l) $0.34(l)

Weighted average common

shares - basic 38,885 38,885

Weighted average common

shares - diluted 40,715(l) 40,715(l)

(a) In calculating net income or loss on an adjusted cash basis, the

Company excludes from net income or loss (i) certain non-cash

charges including amortization expense and stock-based compensation

expense, (ii) non-recurring charges and income, and (iii) certain

other charges and income that have a sign
'/>"/>

SOURCE Inverness Medical Innovations
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
2. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
3. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
4. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
5. Inverness Medical Innovations Acquires ParadigmHealth
6. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
7. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
8. Inverness - Chemogen Establish Exclusive License for TB Antibodies
9. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
10. B-Line Medical and Immersion Medical Announce Partnership
11. MIT researcher addresses biomedical engineering challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: ... sustainable chemicals, today announced that the underwriters of its ... to purchase an additional 420,000 shares of common ... per share, less underwriting discounts and commissions, in ... of 2,800,000 shares of common stock, bringing the ...
(Date:7/23/2014)... , July 23, 2014 ... ), the global specialty biopharmaceutical company, and ArmaGen, ... a worldwide licensing and collaboration agreement for AGT-182, ... potential treatment of both the central nervous system ... syndrome (MPS II). This collaboration strengthens Shire,s rare ...
(Date:7/23/2014)... , July 23, 2014  Sofinnova Ventures, a ... today announced the closing of Sofinnova Venture Partners IX, ... in excess of the initial fund target of $425 ... build successful biotechnology companies. Consistent with recent funds, SVP ... later stage clinical programs, along with select investments in ...
(Date:7/23/2014)... California (PRWEB) July 23, 2014 With the ... in HD resolution for more than 15 minutes, Fastec Imaging ... the world of high speed imaging. “Finally, a high speed ... camera we use in our everyday lives.” proclaims Matt Kearney, ... Fastec has always been to demystify and simplify the traditionally ...
Breaking Biology Technology:BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 2Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 4Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 5Sofinnova Raises $500 Million Biotech Venture Fund 2Fastec Imaging Introduces the First High Speed Camcorder 2Fastec Imaging Introduces the First High Speed Camcorder 3
... ... the Development and Optimization of Crystallization Processes, a method will be presented which facilitates ... of qualitative supersaturation trajectories. , ... (PRWEB) October 9, 2009 -- The quantitative use of in situ ATR-FTIR ...
... Medicago Inc. (TSX-V: MDG), a biotechnology company focused ... on proprietary manufacturing technologies and Virus-Like Particles (VLPs), ... proof of concept contract by the U.S. Army ... Edgewood Chemical Biological Center ("ECBC") Research & Technology ...
... ... , ... York (PRWEB) October 8, 2009 -- iCardiac Technologies, Inc., a global leader in advanced ... has awarded iCardiac a comprehensive cardiac safety study. iCardiac will provide end-to-end study ...
Cached Biology Technology:Calibration Free Supersaturation Assessment and Control for the Development and Optimization of Crystallization Processes 2Medicago awarded contract by the U.S. Army to explore applications of its plant-based technology in renewable energy 2Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 2
(Date:7/23/2014)... . , Proteins ... and transmit signals. To perform these manifold tasks, they ... Planck Institute for Developmental Biology in Tbingen have now ... acid chains even when their three-dimensional shapes differ significantly. ... from common precursors. Presumably, in the course of evolution ...
(Date:7/23/2014)... As local and national governments struggle to deal with ... now refining the picture of just how much there ... the ACS journal Environmental Science & Technology , ... that developed countries discard floods into just seven developing ... people who live there. , Knut Breivik and colleagues ...
(Date:7/23/2014)... starfish, and corals have in common? Aside from ... that use calcium from their environment to create ... protection. , The July issue of The ... Laboratory, addresses the challenges faced by these species ... carbon dioxide rises, the world,s oceans are becoming ...
Breaking Biology News(10 mins):Protein evolution follows a modular principle 2Calcification in changing oceans explored in special issue of The Biological Bulletin 2
... , NEW YORK, Oct. 27 Global Rainmakers, Inc., ... today announced that the company has exited its "stealth" ... of technologies designed to leverage cutting-edge biometric security offerings. ... spent tens of millions of dollars to develop and ...
... blood, normally take the shape of circular cushions with a ... an asymmetrical slipper shape. A team of physicists have ... for this deformation, as well as how the deformation in ... mechanisms involved in arterial disease and other blood flow-related ailments. ...
... Contrary to a national trend, more and more ... in math and science. Thanks to a $307,277 grant ... in the sciences at RutgersCamden will receive unprecedented support ... their degrees. Through a new RutgersCamden program titled ...
Cached Biology News:Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3NSF grant supports Rutgers-Camden program for science majors 2NSF grant supports Rutgers-Camden program for science majors 3
... CHEMICON MDR1 Shift Assay provides a convenient method ... upon transport of MDR1 substrates. Thus, the kit ... which small molecules act as transport substrates for ... the presence of MDR1 substrates, the MDR1 Shift ...
... microarrays are derived from frozen embedded tissue ... control procedures to ensure the highest quality. ... in one block, sectioned at a thickness ... slides. Sections are large (3-5 mm in ...
... Zyagen tissue microarrays are derived from frozen ... rigorous quality control procedures to ensure the ... manually assembled in one block, sectioned at ... coated slides. Sections are large (3-5mm in ...
... from Paraffin embedded tissue blocks, which are ... ensure the highest quality. Tissues of each ... sectioned at a thickness of 5 microns ... large (3-5mm in diameter) in comparison to ...
Biology Products: